Q1 2025 Earnings Call Transcript May 1, 2025 Alkermes plc misses on earnings expectations. Reported EPS is $0.13 EPS, expectations were $0.28. Operator: Greetings, and welcome to Alkermes’ First ...

Gilead Sciences, Inc. today announced new data from multiple analyses which reinforce that Livdelzi® (seladelpar), known as Lyvdelzi® in the European Union, is effective and generally well-tolerated ...

The orexin 2 receptor agonist pathway has broad potential ... of the Phase 2 program is to more fully elaborate the dose response curve in larger patient populations, define the lower and upper ...

The leading Merkel Cell Carcinoma Companies such as ImmunityBio, OncoSec Medical, Exelixis, 4SC, Kartos Therapeutics, Incyte ...

This fact is especially pertinent in cancer therapy, where most cytotoxic agents have a steep dose–response curve for toxicity and, consequently, narrow therapeutic windows. Capecitabine (Xeloda ...

Objective: To review drug interaction studies of glucagon-like peptide-1 receptor agonists (GLP-1RAs) and concurrent oral medications. Data Sources: PubMed was searched (to December 5, 2011 ...

Enhance your organization’s ability to deal with malware by bringing security and sanity to initial infection response efforts. Dynamic Download — This asset consists of a four-page PDF ...

The mean dose showed an AUC of 0.707, with a cutoff of 89.5Gy, sensitivity of 61.9%, and specificity of 68.7%. ROC curves were engendered to distinguish the objective response using mean dose and Y90 ...